ImmuCell Corporation
ICCC
$9.92
$0.151.54%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 27.64M | 27.77M | 28.27M | 27.30M | 26.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.64M | 27.77M | 28.27M | 27.30M | 26.49M |
| Cost of Revenue | 16.20M | 16.40M | 17.69M | 18.30M | 18.55M |
| Gross Profit | 11.45M | 11.37M | 10.59M | 9.00M | 7.94M |
| SG&A Expenses | 5.95M | 5.94M | 5.66M | 5.83M | 5.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.19M | 25.44M | 26.54M | 27.53M | 28.13M |
| Operating Income | 2.45M | 2.33M | 1.73M | -222.50K | -1.64M |
| Income Before Tax | -1.03M | 2.34M | 1.77M | -261.20K | -2.15M |
| Income Tax Expenses | 11.60K | 14.30K | 11.10K | 10.50K | 9.90K |
| Earnings from Continuing Operations | -1.04 | 2.32 | 1.76 | -0.27 | -2.16 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.04M | 2.32M | 1.76M | -271.70K | -2.16M |
| EBIT | 2.45M | 2.33M | 1.73M | -222.50K | -1.64M |
| EBITDA | 5.18M | 5.03M | 4.43M | 2.47M | 1.05M |
| EPS Basic | -0.11 | 0.26 | 0.19 | -0.06 | -0.28 |
| Normalized Basic EPS | 0.15 | 0.14 | 0.09 | -0.07 | -0.17 |
| EPS Diluted | -0.12 | 0.25 | 0.18 | -0.07 | -0.29 |
| Normalized Diluted EPS | 0.15 | 0.14 | 0.09 | -0.07 | -0.17 |
| Average Basic Shares Outstanding | 36.10M | 35.99M | 35.11M | 33.89M | 32.66M |
| Average Diluted Shares Outstanding | 36.25M | 35.99M | 35.11M | 33.89M | 32.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |